🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,063 results for “BRIGHT MINDS BIOSCIENCES INC.” Clear

  1. Behavioral Couples Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Abuse

    phase 2 other completed

    1 trial

  2. Behavioral Drug and Risk Counseling (BDRC)

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Risk Behaviors

    phase 2 other completed

    1 trial

  3. Benznidazole

    BRIGHT MINDS BIOSCIENCES INC.

    Trypanosoma Cruzi Infection

    phase 2 small molecule completed

    1 trial

  4. Bevacizumab

    BRIGHT MINDS BIOSCIENCES INC.

    Colorectal Neoplasms

    phase 2 small molecule terminated

    1 trial

  5. Bevacizumab

    BRIGHT MINDS BIOSCIENCES INC.

    Breast Cancer

    phase 2 small molecule completed

    1 trial

  6. Blinded study medication

    BRIGHT MINDS BIOSCIENCES INC.

    Knee Osteoarthritis

    phase 2 small molecule completed

    1 trial

  7. Brief computer-delivered intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    phase 2 other completed

    1 trial

  8. Brief motivational intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use

    phase 2 other completed

    1 trial

  9. Brief motivational intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse Detection

    phase 2 other completed

    1 trial

  10. Brincidofovir

    BRIGHT MINDS BIOSCIENCES INC.

    Ebola Virus Disease

    phase 2 small molecule terminated

    1 trial

  11. BufferGel

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 2 small molecule completed

    1 trial

  12. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Addiction

    phase 2 small molecule completed

    1 trial

  13. Buprenorphine Naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Maternal Opioid Use Disorder

    phase 2 small molecule completed

    1 trial

  14. Buprenorphine SL

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 2 small molecule active

    1 trial

  15. Buprenorphine and Outpatient Parenteral Antibiotic Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Use

    phase 2 small molecule completed

    1 trial

  16. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 2 small molecule completed

    1 trial

  17. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia and Disorders With Psychotic Features

    phase 2 small molecule completed

    1 trial

  18. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Dependence

    phase 2 small molecule completed

    1 trial

  19. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine

    phase 2 small molecule completed

    1 trial

  20. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Abuse

    phase 2 small molecule completed

    1 trial

  21. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    1 trial

  22. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    phase 2 small molecule active

    2 trials

  23. Bupropion SR 150mg tabs

    BRIGHT MINDS BIOSCIENCES INC.

    Adolescent Methamphetamine Abuse

    phase 2 small molecule completed

    1 trial

  24. Bupropion and NRT

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources